Gene · 4635
Papers540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myosin essential light chain 1sa decelerates actin and thin filament gliding on β-myosin molecules. | J Gen Physiol | 2022 | 36053243 | PubTator, text mining | PubMed |
| Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution. | Front Oncol | 2022 | 36003795 | PubTator, text mining | PubMed |
| Identification and genetic analysis of rare variants in myosin family genes in 412 Han Chinese congenital heart disease patients. | Mol Genet Genomic Med | 2022 | 35993536 | PubTator, text mining | PubMed |
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. | J Arrhythm | 2022 | 35936045 | PubTator, text mining | PubMed |
| Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. | Science | 2022 | 35926050 | PubTator, text mining | PubMed |
| Atrial cardiomyopathy: from cell to bedside. | ESC Heart Fail | 2022 | 35920287 | PubTator, text mining | PubMed |
| Functional isolation, culture and cryopreservation of adult human primary cardiomyocytes. | Signal Transduct Target Ther | 2022 | 35882831 | PubTator, text mining | PubMed |
| RNA-seq-driven expression analysis to investigate cardiovascular disease genes with associated phenotypes among atrial fibrillation patients. | Clin Transl Med | 2022 | 35875838 | PubTator, text mining | PubMed |
| Relationship between Serum miR-106 and MYL4 Levels and the Prevalence, Risk Stratification, and Prognosis of Atrial Fibrillation. | J Immunol Res | 2022 | 35874900 | PubTator, text mining | PubMed |
| Insight Into the Metabolic Adaptations of Electrically Pulse-Stimulated Human Myotubes Using Global Analysis of the Transcriptome and Proteome. | Front Physiol | 2022 | 35874526 | PubTator, text mining | PubMed |
| Quantitative proteome remodeling characterization of two human reference pluripotent stem cell lines during neurogenesis and cardiomyogenesis. | Proteomics | 2022 | 35871287 | PubTator, text mining | PubMed |
| The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates. | Front Cardiovasc Med | 2022 | 35859594 | PubTator, text mining | PubMed |
| Effects of macrophages on the proliferation and cardiac differentiation of human induced pluripotent stem cells. | Cell Commun Signal | 2022 | 35850719 | PubTator, text mining | PubMed |
| Left Atrial Cardiomyopathy - A Challenging Diagnosis. | Front Cardiovasc Med | 2022 | 35845077 | PubTator, text mining | PubMed |
| Why is endothelial resilience key to maintain cardiac health? | Basic Res Cardiol | 2022 | 35834003 | PubTator, text mining | PubMed |
| Grey wolf genomic history reveals a dual ancestry of dogs. | Nature | 2022 | 35768506 | PubTator, text mining | PubMed |
| Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis. | Front Immunol | 2022 | 35734167 | PubTator, text mining | PubMed |
| The Underlying Molecular Basis and Mechanisms of Venous Thrombosis in Patients with Osteomyelitis: A Data-Driven Analysis. | Genet Res (Camb) | 2022 | 35711689 | PubTator, text mining | PubMed |
| Genetic analysis of right heart structure and function in 40,000 people. | Nat Genet | 2022 | 35697867 | PubTator, text mining | PubMed |
| Transcriptional Effects of Candidate COVID-19 Treatments on Cardiac Myocytes. | Front Cardiovasc Med | 2022 | 35686037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4635/papers?page=6